"Proton Pump Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.
| Descriptor ID |
D054328
|
| MeSH Number(s) |
D27.505.519.389.848
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proton Pump Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Proton Pump Inhibitors".
This graph shows the total number of publications written about "Proton Pump Inhibitors" by people in this website by year, and whether "Proton Pump Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 3 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 25 | 11 | 36 |
| 2018 | 32 | 12 | 44 |
| 2019 | 8 | 13 | 21 |
| 2020 | 7 | 3 | 10 |
| 2021 | 2 | 1 | 3 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Proton Pump Inhibitors" by people in Profiles.
-
Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19. Eur J Gastroenterol Hepatol. 2022 02 01; 34(2):137-141.
-
Response to "Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy". Am J Gastroenterol. 2021 12 01; 116(12):2474.
-
Proton Pump Inhibitors and COVID-19: Confusing Status Quo. Am J Gastroenterol. 2021 10 01; 116(10):2153.
-
Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19 Turk J Med Sci. 2021 08 30; 51(3):1675-1681.
-
COVID-19 Mortality: The Culprit May Not Be Proton Pump Inhibitors. Clin Gastroenterol Hepatol. 2022 01; 20(1):247-248.
-
Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy. Am J Gastroenterol. 2021 08 01; 116(8):1638-1645.
-
Case Report: Systemic Sclerosis After Covid-19 Infection. Front Immunol. 2021; 12:686699.
-
Does Proton Pump Inhibitor Use Lead to a Higher Risk of Coronavirus Disease 2019 Infection and Progression to Severe Disease? a Meta-analysis. Jpn J Infect Dis. 2022 Jan 24; 75(1):10-15.
-
Proton pump inhibitors in the COVID-19 pandemic. Gastroenterol Hepatol. 2021 11; 44(9):611-613.
-
Proton Pump Inhibitor Use Is Not Strongly Associated With SARS-CoV-2 Related Outcomes: A Nationwide Study and Meta-analysis. Clin Gastroenterol Hepatol. 2021 09; 19(9):1845-1854.e6.